Evaluation of a Conservative Treatment by Nocturnal Wrist Orthosis in the Non-surgical Management of Carpal Tunnel Syndrome (AMYLYONCARP)

NCT ID: NCT05483218

Last Updated: 2024-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-27

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study focuses on the evaluation of 2 nocturnal wrist orthosis prescribed as part of a non-surgical management of carpal tunnel syndrome in order to determine their effectiveness in reducing the symptoms associated with the syndrome and to highlight the superiority or the inferiority of one over the other.

It will also be possible to assess their comfort and compliance as well as the impact of wearing them on neurological and muscular recovery (functional assessment).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After selection of patients suffering from carpal tunnel syndrome during consultation visits, the study will be explained to them, an information sheet and a consent form will be given to them.

A subgroup of patients who have undergone a diagnostic electromyogram at the study center (defined as a functional assessment subgroup) will be randomized independently of the other participants (2 randomization lists will be generated).

The randomization will be done on 2 groups: one benefiting from a wrist orthosis called simple rest, and the other from a wrist-hand-finger orthosis called global rest.

An appointment for making the orthosis will be fixed with the manufacturer within one month of inclusion.

The follow-up will then be done by 2 telephone collection visits at 1 month then at 2 months of the implementation of the device then by a last visit at 3 months consisting in a consultation for the functional assessment subgroup and a phone call for the others.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

wrist orthosis

group benefiting from an orthosis that supports the wrist by covering the palm of the hand only

Group Type EXPERIMENTAL

Nocturnal wrist orthosis wearing

Intervention Type DEVICE

Nocturnal wearing of one of the 2 wrist orthosis kind

wrist-hand-finger orthosis

group benefiting from an orthosis that supports the wrist by covering the palm of the hand and the fingers

Group Type EXPERIMENTAL

Nocturnal wrist orthosis wearing

Intervention Type DEVICE

Nocturnal wearing of one of the 2 wrist orthosis kind

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nocturnal wrist orthosis wearing

Nocturnal wearing of one of the 2 wrist orthosis kind

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age with unilateral or bilateral, idiopathic or secondary carpal tunnel syndrome, without surgical indication (EMG with myelin sensory signs without axonal involvement)
* signed consent
* Affiliation to social security

Exclusion Criteria

* Patients with carpal tunnel syndrome with severity criteria
* Patient refusal
* Patient with disorders (psychological, behavioral) that may lead to poor compliance with the study treatment
* Presence of skin lesion in the area of the orthosis
* Current participation in another research protocol involving the human person
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Saint Joseph Saint Luc de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Neurologique Pierre Wertheimer - Hospices Civils de Lyon

Bron, , France

Site Status RECRUITING

Centre Hospitalier Saint Joseph Saint Luc

Lyon, , France

Site Status RECRUITING

Centre Orthopédique Santy

Lyon, , France

Site Status RECRUITING

SELARL de Neurologie Bullukian

Lyon, , France

Site Status RECRUITING

Médipôle Hôpital Mutualiste

Villeurbanne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe SCHIELE, MD

Role: CONTACT

0 478 618 624 ext. +33

Stéphane RIO, M.

Role: CONTACT

0 478 61 8 216 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Françoise BOUHOUR, MD

Role: primary

472 118 063 ext. +33

Philippe Schiele, MD

Role: primary

478 618 216 ext. +33

Stéphane Rio

Role: backup

478 618 216 ext. +33

Jordane SAUNIER, MD

Role: primary

437 530 038 ext. +33

Nadia VANDENBERGHE, MD

Role: primary

472 340 690 ext. +33

Aurore BRAQUET, MD

Role: primary

481 655 296 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ORTHO-2C

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Carpal Tunnel Release Efficacy Trial
NCT06934187 NOT_YET_RECRUITING NA